Inventor · disambiguated record
Qihong Liu
Also filed as: LIU QIHONG
11 granted patents·5 pending applications·8 citations·filing 2007–2021
81Inventor score
Files withSHANGHAI FOCHON PHARMACEUTICAL CO LTD6FOCHON BIOSCIENCES LTD4FOCHON PHARMACEUTICALS LTD3LAUDERDALE II ROBERT P2CHONGQING FOCHON PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
16 records- 0173US10087195B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 2, 2018·2 cites·14 claims
- 0271US9556171B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jan 31, 2017·2 cites·15 claims
- 0366US8687494B2System and method for Ec/Io access screening in a CDMA networkLAUDERDALE II ROBERT P·Filed 2012·Granted Apr 1, 2014·2 cites·20 claims
- 0459US8159951B2System and method for Ec/Io access screening in a CDMA networkLAUDERDALE II ROBERT P·Filed 2007·Granted Apr 17, 2012·2 cites·21 claims
- 0551US2023159527A1Compounds as bcl-2 inhibitorsFOCHON PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 0649US2023406856A1SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORSFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 0748US2023174556A1Compounds as protein kinase inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 0845US10022374B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 17, 2018·0 cites·13 claims
- 0945US2022235049A1SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3,4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORSFOCHON PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1040US2022041588A1Substituted imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine compounds as ret kinase inhibitorsFOCHON PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 1139US11168078B2Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenaseSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 9, 2021·0 cites·17 claims
- 1236US11555042B2Macrocyclic compounds as TRK kinases inhibitorsFOCHON BIOSCIENCES LTD·Filed 2019·Granted Jan 17, 2023·0 cites·31 claims
- 1336US11459332B2Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitorsFOCHON BIOSCIENCES LTD·Filed 2019·Granted Oct 4, 2022·0 cites·22 claims
- 1436US10894038B2Indolizine derivatives, composition and methods of useSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 19, 2021·0 cites·20 claims
- 1534US10450316B2Certain protein kinase inhibitorCHONGQING FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·0 cites·16 claims
- 1633US10328060B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 25, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Qihong Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →